Format

Send to

Choose Destination
Chest. 2016 May;149(5):1340-4. doi: 10.1016/j.chest.2015.11.020. Epub 2015 Dec 12.

Update on Exhaled Nitric Oxide in Clinical Practice.

Author information

1
Department of Pulmonary, Critical Care, and Sleep Medicine, Tuality Healthcare, Hillsboro, OR.
2
Department of Pulmonary, Critical Care, and Sleep Medicine, Tuality Healthcare, Hillsboro, OR. Electronic address: hahnpy@gmail.com.

Abstract

Asthma is characterized by chronic airway inflammation. Fractional exhaled nitric oxide (Feno) has emerged as a marker of T-helper cell type 2-mediated allergic airway inflammation. Recent studies suggest a role for Feno testing as a point-of-care tool in the management of patients with asthma. This Topics in Practice Management article reviews current coverage and reimbursement issues related to Feno testing and provides an overview of pertinent recent studies.

KEYWORDS:

asthma; nitric oxide

PMID:
26836891
DOI:
10.1016/j.chest.2015.11.020
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center